Dodd reintroduces sunscreen monograph bill
This article was originally published in The Rose Sheet
Executive SummarySen. Chris Dodd, D-Conn., has reintroduced a bill imposing a deadline on FDA to finalize monograph for broad-spectrum sunscreen ingredients that protect consumers from UVA and UVB rays. The bill, S. 1112, will be reviewed by the Senate Health, Education, Labor and Pensions Committee. Rep. Nita Lowey, D-N.Y., reintroduced the House version of the bill - the Skin Cancer Prevention, Education and Consumer Right-To-Know Act - in April. Lowey's bill was referred to the House Energy and Commerce Committee
You may also be interested in...
So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.